Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Oncology (Williston Park, N.Y.)|February 12, 1998
Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancerJ L González-Larriba, I Garcia Carbonero, J Sastre Valera, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 3, 2007
Sorafenib TARGET trial results in Spanish patientsJ Bellmunt, J L González-Larriba, M A Climent, et al.Revista Clinica Espanola|October 1, 1991
[Superior vena cava syndrome in microcytic carcinoma of the lung: incidence, treatment response and prognostic importance]M P Morales, M Martín, E Díaz-Rubio, et al.European Journal of Cancer Care|January 22, 2010
Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumoursA López-Pousa, J Rifà, A Casas de Tejerina, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Single agent Taxol, 3-hour infusion, in untreated advanced non-small-cell lung cancerV Alberola, R Rosell, J L González-Larriba, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Ifosfamide in advanced epidermoid head and neck cancerM Martín, E Diaz-Rubio, J L González Larriba, et al.Cancer Investigation|January 1, 1992
Treatment of advanced colorectal cancer with recombinant interferon alpha and fluorouracil: activity in liver metastasisE Díaz Rubio, J Jimeno, C Camps, et al.Oncology|February 23, 2013
Erlotinib versus pemetrexed for pretreated non-squamous non-small cell lung cancer patients in clinical practiceJ Zugazagoitia, J Puente, J L González-Larriba, et al.Lung Cancer (Amsterdam, Netherlands)|February 18, 1999
Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)A Antón, N Díaz-Fernández, J L González Larriba, et al.Pageof 4